Skip to main content
Updating results

Pharmaceutical Manufacturing

  • Updated

CARSON CITY, Nev. (AP) — The Nevada website the public uses to get information on coronavirus vaccines is packed with more ad trackers and third-party cookies than any state vaccination website in the country, allowing companies to track how visitors navigate the internet and collect data on them that can potentially be used or sold by third parties.

  • Updated

BERLIN (AP) — The head of German pharmaceutical company BioNTech said Monday that there is no need to waive patents on coronavirus vaccines because manufacturers will be able to produce enough shots to supply the world over the coming year.

  • Updated

BRUSSELS (AP) — The European Commission insisted Monday it still trusts the coronavirus vaccine developed by AstraZeneca and that its dispute with the Anglo-Swedish drugmaker is only contractual.

  • Updated

WASHINGTON (AP) — It won’t speed the manufacture of vaccines. It enraged the developers who delivered lifesaving doses in record time. But President Joe Biden’s decision to support waiving intellectual property rights for coronavirus shots had a broader purpose: to broadcast his administration’s commitment to global leadership.

  • Updated

WASHINGTON (AP) — It won’t speed the manufacture of vaccines. It enraged the developers who delivered lifesaving doses in record time. But President Joe Biden’s decision to support waiving intellectual property rights for coronavirus shots had a broader purpose: to broadcast his administration’s commitment to global leadership.

  • Updated

GENEVA (AP) — European leaders voiced increasing skepticism Friday that a U.S. proposal to lift patent protections on COVID-19 vaccines would solve the problem of getting shots into the arms of people in poorer countries, with some instead calling for more exports of the doses already being produced.

Get up-to-the-minute news sent straight to your device.

Topics

News Alerts

Breaking News